PL377609A1 - Pochodne indazolu jako antagoniści CRF - Google Patents
Pochodne indazolu jako antagoniści CRFInfo
- Publication number
- PL377609A1 PL377609A1 PL377609A PL37760903A PL377609A1 PL 377609 A1 PL377609 A1 PL 377609A1 PL 377609 A PL377609 A PL 377609A PL 37760903 A PL37760903 A PL 37760903A PL 377609 A1 PL377609 A1 PL 377609A1
- Authority
- PL
- Poland
- Prior art keywords
- indazole derivatives
- crf antagonists
- crf
- antagonists
- indazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43016802P | 2002-12-02 | 2002-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL377609A1 true PL377609A1 (pl) | 2006-02-06 |
Family
ID=32469420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377609A PL377609A1 (pl) | 2002-12-02 | 2003-11-24 | Pochodne indazolu jako antagoniści CRF |
Country Status (21)
Country | Link |
---|---|
US (2) | US7214699B2 (pl) |
EP (1) | EP1569911B1 (pl) |
JP (1) | JP4401298B2 (pl) |
KR (1) | KR100761562B1 (pl) |
CN (1) | CN100439341C (pl) |
AR (1) | AR042148A1 (pl) |
AT (1) | ATE399768T1 (pl) |
AU (1) | AU2003286180B2 (pl) |
BR (1) | BR0316950A (pl) |
CA (1) | CA2507074A1 (pl) |
DE (1) | DE60321958D1 (pl) |
ES (1) | ES2309368T3 (pl) |
GT (1) | GT200300263A (pl) |
MX (1) | MXPA05005794A (pl) |
PA (1) | PA8589601A1 (pl) |
PE (1) | PE20040764A1 (pl) |
PL (1) | PL377609A1 (pl) |
RU (1) | RU2341518C2 (pl) |
TW (1) | TW200418816A (pl) |
UY (1) | UY28105A1 (pl) |
WO (1) | WO2004050634A1 (pl) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
RU2376292C2 (ru) * | 2003-08-14 | 2009-12-20 | Ф.Хоффманн-Ля Рош Аг | Гамк-ергические модуляторы |
US6984652B2 (en) * | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
TW200616967A (en) * | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
MX2007000791A (es) * | 2004-08-03 | 2007-03-23 | Wyeth Corp | Indazoles utiles en el tratamiento de enfermedades cardiovasculares. |
US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
WO2007115966A1 (en) * | 2006-04-11 | 2007-10-18 | F. Hoffmann-La Roche Ag | Heterocyclic gaba alpha subtype selective receptor modulators |
ITMI20062230A1 (it) * | 2006-11-22 | 2008-05-23 | Acraf | Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende |
AR065804A1 (es) | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3239170B1 (en) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
WO2012026511A1 (ja) * | 2010-08-27 | 2012-03-01 | 協和発酵キリン株式会社 | 医薬組成物 |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
SG10202004716RA (en) * | 2014-07-24 | 2020-06-29 | Beta Pharma Inc | 2-h-indazole derivatives as cyclin-dependent kinase (cdk) inhibitors and therapeutic uses thereof |
KR101713303B1 (ko) * | 2015-12-24 | 2017-03-07 | 강원대학교산학협력단 | 2h-인다졸 유도체의 제조방법 |
WO2022107064A1 (en) | 2020-11-20 | 2022-05-27 | Idemitsu Kosan Co., Ltd. | Heterocyclic compound and an organic electroluminescence device comprising the heterocyclic compound |
CN113831319A (zh) * | 2021-10-19 | 2021-12-24 | 北京科技大学 | 含有大位阻取代基芳基硼酸/硼酸酯的铃木反应方法 |
KR20230081778A (ko) | 2021-11-29 | 2023-06-08 | 조이운 | VOCs 저감장치 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69323212T2 (de) * | 1992-12-17 | 1999-05-27 | Pfizer | Pyrazole mit crf antagonistischer aktivität |
US6005109A (en) * | 1997-10-30 | 1999-12-21 | Pflizer Inc. | Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
FR2701026B1 (fr) * | 1993-02-02 | 1995-03-31 | Adir | Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
US5705646A (en) * | 1993-09-30 | 1998-01-06 | Pfizer Inc. | Substituted pyrazoles as CRF antagonists |
US5668145A (en) * | 1993-11-12 | 1997-09-16 | Pfizer Inc. | Amino-substituted pyrazoles having CRF antagonistic activity |
US5646152A (en) * | 1994-06-15 | 1997-07-08 | Pfizer Inc. | Methods of administering CRF antagonists |
US5760225A (en) * | 1996-11-15 | 1998-06-02 | Neurogen Corporation | Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands |
JP2001521926A (ja) | 1997-11-04 | 2001-11-13 | ファイザー・プロダクツ・インク | 治療上活性の化合物におけるカテコールのインダゾール生物学的等価物置換 |
GB9824310D0 (en) * | 1998-11-05 | 1998-12-30 | Univ London | Activators of soluble guanylate cyclase |
CA2399791A1 (en) * | 2000-02-11 | 2001-08-16 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
CA2413002A1 (en) * | 2000-06-30 | 2002-12-19 | Banyu Pharmaceutical Co., Ltd. | Novel pyrazinone derivatives |
US6897231B2 (en) * | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
WO2002016348A1 (en) * | 2000-08-09 | 2002-02-28 | Astrazeneca Ab | Antiangiogenic bicyclic derivatives |
US20030109550A1 (en) * | 2001-09-19 | 2003-06-12 | Michael Clare | Substituted indazole compounds for the treatment of inflammation |
FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
TW200409759A (en) * | 2002-09-25 | 2004-06-16 | Wyeth Corp | Substituted 4-(indazol-3-yl)phenols |
-
2003
- 2003-11-24 BR BR0316950-2A patent/BR0316950A/pt not_active IP Right Cessation
- 2003-11-24 ES ES03776916T patent/ES2309368T3/es not_active Expired - Lifetime
- 2003-11-24 MX MXPA05005794A patent/MXPA05005794A/es active IP Right Grant
- 2003-11-24 WO PCT/EP2003/013161 patent/WO2004050634A1/en active IP Right Grant
- 2003-11-24 CA CA002507074A patent/CA2507074A1/en not_active Abandoned
- 2003-11-24 KR KR1020057009878A patent/KR100761562B1/ko not_active IP Right Cessation
- 2003-11-24 RU RU2005120770/04A patent/RU2341518C2/ru not_active IP Right Cessation
- 2003-11-24 AT AT03776916T patent/ATE399768T1/de not_active IP Right Cessation
- 2003-11-24 PL PL377609A patent/PL377609A1/pl not_active Application Discontinuation
- 2003-11-24 EP EP03776916A patent/EP1569911B1/en not_active Expired - Lifetime
- 2003-11-24 CN CNB2003801079699A patent/CN100439341C/zh not_active Expired - Fee Related
- 2003-11-24 JP JP2004556171A patent/JP4401298B2/ja not_active Expired - Fee Related
- 2003-11-24 DE DE60321958T patent/DE60321958D1/de not_active Expired - Lifetime
- 2003-11-24 AU AU2003286180A patent/AU2003286180B2/en not_active Ceased
- 2003-11-26 TW TW092133163A patent/TW200418816A/zh unknown
- 2003-11-27 PA PA20038589601A patent/PA8589601A1/es unknown
- 2003-11-28 UY UY28105A patent/UY28105A1/es not_active Application Discontinuation
- 2003-11-28 PE PE2003001215A patent/PE20040764A1/es not_active Application Discontinuation
- 2003-11-28 GT GT200300263A patent/GT200300263A/es unknown
- 2003-11-28 AR ARP030104398A patent/AR042148A1/es unknown
- 2003-12-01 US US10/724,971 patent/US7214699B2/en not_active Expired - Fee Related
-
2007
- 2007-05-02 US US11/799,605 patent/US20070213373A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TW200418816A (en) | 2004-10-01 |
GT200300263A (es) | 2004-06-28 |
BR0316950A (pt) | 2006-01-17 |
KR20050084079A (ko) | 2005-08-26 |
US7214699B2 (en) | 2007-05-08 |
RU2005120770A (ru) | 2006-02-10 |
KR100761562B1 (ko) | 2007-10-04 |
US20070213373A1 (en) | 2007-09-13 |
JP4401298B2 (ja) | 2010-01-20 |
RU2341518C2 (ru) | 2008-12-20 |
WO2004050634A1 (en) | 2004-06-17 |
ATE399768T1 (de) | 2008-07-15 |
CN1732158A (zh) | 2006-02-08 |
EP1569911A1 (en) | 2005-09-07 |
CA2507074A1 (en) | 2004-06-17 |
AR042148A1 (es) | 2005-06-08 |
JP2006510625A (ja) | 2006-03-30 |
MXPA05005794A (es) | 2005-08-16 |
PA8589601A1 (es) | 2004-09-16 |
AU2003286180A1 (en) | 2004-06-23 |
PE20040764A1 (es) | 2004-11-06 |
ES2309368T3 (es) | 2008-12-16 |
US20040110815A1 (en) | 2004-06-10 |
DE60321958D1 (de) | 2008-08-14 |
CN100439341C (zh) | 2008-12-03 |
AU2003286180B2 (en) | 2009-11-12 |
EP1569911B1 (en) | 2008-07-02 |
UY28105A1 (es) | 2004-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL377609A1 (pl) | Pochodne indazolu jako antagoniści CRF | |
AP2005003343A0 (en) | Substituted pyrrolo-pyrazole derivatives as kinaseinhibitors | |
AP1850A (en) | Spiroindolineplperidine derivatives | |
EG24050A (en) | Heterocylocarboxamide derivatives | |
PL377778A1 (pl) | Pochodne pirazolu | |
IL165515A0 (en) | Bisindolyl-maleimid derivatives as kinase inhibitors | |
IL163892A0 (en) | Indolylmaleimide derivatives | |
HK1077068A1 (en) | Azolidinone-vinyl fused-benzene derivatives | |
IL166121A0 (en) | Indole-3-sulphur derivatives | |
EP1522540A4 (en) | AZAARENE DERIVATIVES | |
IL165810A0 (en) | Novel benzimidazole derivatives | |
HK1072259A1 (en) | Indole derivatives useful as histamine h3 antagonists | |
PL376475A1 (pl) | Pochodne N-podstawionej 2-oksodihydropirydyny | |
ZA200500471B (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
GB0315870D0 (en) | Heterocyclic derivatives | |
IL173911A0 (en) | Imidazole derivatives | |
AU2003273885A1 (en) | Morpholine-bridged indazole derivatives | |
IL172821A0 (en) | Imidazole derivatives iii | |
AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
GB0213488D0 (en) | 2-Naphthamide derivatives | |
AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
AU2003286316A1 (en) | 5-aminophenanthridine derivatives as npy-5 antagonists | |
GB0220962D0 (en) | Heterocyclic derivatives | |
GB0220961D0 (en) | Heterocyclic derivatives | |
SI1654253T1 (sl) | Substituirani 3-pirolidin-indolni derivati |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |